February 20, 2018 / 9:51 PM / 4 months ago

BRIEF-Portola Pharmaceuticals Announces Results Of CHMP Oral Explanations For Andexanet Alfa And Betrixaban

Feb 20 (Reuters) - Portola Pharmaceuticals Inc:

* PORTOLA PHARMACEUTICALS ANNOUNCES RESULTS OF CHMP ORAL EXPLANATIONS FOR ANDEXANET ALFA AND BETRIXABAN

* PORTOLA PHARMA SAYS COMMITTEE FOR CHMP OF EMA COMMUNICATED POSITIVE TREND VOTE ON MARKETING AUTHORISATION APPLICATION FOR ANDEXANET ALFA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below